First Health Pharmaceuticals B.V.

Contact: Mrs. A. Tarditi

Science Park 408, 1098 XH Amsterdam

RNA Helicase Inhibitors with antiviral and anti tumor properties

Broad spectrum Antivirals and Anti-tumor agents


First Health Pharmaceuticals develops DDX3 RNA Helicase inhibitors with broad spectrum antiviral properties including HIV, Dengue and HCV and anti tumor activity against some of the most challenging types of cancer such as Breast, Lung and Prostate Cancer.

Founded: 30-03-2015
Situated in Amsterdam Science Park: 01-06-2016
Number of employees: Ca. 20 staff and international collaborators performing contract- and/or sponsored research